Cinclus Pharma Holding AB (publ) (STO:CINPHA)

Cinclus Pharma Holding AB Revenue

Cinclus Pharma Holding AB had revenue of 10.04M SEK in the quarter ending March 31, 2026. This brings the company's revenue in the last twelve months to 67.51M, up 1,373.93% year-over-year. In the year 2025, Cinclus Pharma Holding AB had annual revenue of 57.47M with 1,154.80% growth.

• Revenue (ttm): 67.51M
• Revenue Growth: +1,373.93%
• P/S Ratio: 8.42
• Revenue / Employee: 3.21M
• Employees: 21
• Market Cap: 568.69M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	57.47M	52.89M	1,154.80%
Dec 31, 2024	4.58M	-1.38M	-23.14%
Dec 31, 2023	5.96M	-4.61M	-43.63%
Dec 31, 2022	10.57M	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 12, 2026

Data Sources Report a data error